Injectable contraception in shock link to increased risk of brain tumour
by Jane Kirby
Mar 27, 2024
3 minutes
An injectable contraception used by some women in the UK has been linked to an increased risk of a type of brain tumour.
A study, published in the British Medical Journal (BMJ), found people using injectable medroxyprogesterone acetate for more than a year appear to have a higher risk of meningioma – a tumour of the membranes covering the brain and spinal cord.
It is usually benign but can cause serious
You’re reading a preview, subscribe to read more.
Start your free 30 days